OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
EIFG58

MedNation AG

Healthcare Facilities & ServicesVerified

MedNation’s capital structure shows a debt-to-equity ratio of 1.06, indicating moderate leverage, with long-term debt of EUR 12.33 million against equity of EUR 11.59 million. The company maintains a current ratio of 1.57, suggesting sufficient short-term liquidity to cover obligations, though net cash is negative after subtracting total debt. Profitability metrics reveal a return on equity (ROE) of 0.9% and a return on assets (ROA) of 0.29%, both below the typical thresholds for healthcare facilities, which often aim for ROE above 10% and ROA above 5%. Operating income of EUR 1.37 million on revenue of EUR 48.76 million yields a 2.8% margin, which is weak compared to industry benchmarks. The company’s geographic exposure is concentrated in Germany, with three primary clinics in Bonn, Moenchengladbach, and Bad Wuennenberg. Revenue is not disclosed by segment, but the ownership structure suggests a focus on orthopedics, geriatrics, and cardiology. The company also holds a minority stake in a geriatric center, indicating diversification within the senior care segment. Growth appears limited, with the most recent actual revenue of EUR 36.91 million reported in the IR observations, compared to the latest financial snapshot of EUR 48.76 million. This suggests a recent increase, but the outlook for the next fiscal year is not explicitly provided. Free cash flow of EUR 651,000 and capital expenditures of EUR -871,000 indicate a net outflow, which may constrain reinvestment. Risk factors include medium liquidity risk due to a current ratio of 1.57 and a negative net cash position after debt. Dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted figures. The company’s capital structure is stable, but the low ROE and ROA suggest operational inefficiencies that could affect long-term value. Recent events include the rebranding from Eifelhoehen-Klinik AG to MedNation AG, reflecting a strategic shift toward a broader healthcare services identity. No recent filings or transcripts are provided, but the company’s ownership of multiple clinics and a minority stake in a geriatric center suggests a focus on expanding its footprint in Germany’s aging population.

30-day price · EIFG+0.26 (+7.4%)
Low$3.20High$3.80Close$3.76As of17 May, 00:00 UTC
Profile
CompanyMedNation AG
TickerEIFG.DE
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. MedNation AG operates three specialist clinics in Germany, providing outpatient and inpatient rehabilitation, geriatric care, and cardiac and orthopedic services, generating revenue primarily through healthcare facility operations.

Classification. MedNation is classified in the Healthcare Facilities & Services industry under the Healthcare Services & Equipment business sector, with a confidence level of 0.92 based on verified market data.

MedNation’s capital structure shows a debt-to-equity ratio of 1.06, indicating moderate leverage, with long-term debt of EUR 12.33 million against equity of EUR 11.59 million. The company maintains a current ratio of 1.57, suggesting sufficient short-term liquidity to cover obligations, though net cash is negative after subtracting total debt. Profitability metrics reveal a return on equity (ROE) of 0.9% and a return on assets (ROA) of 0.29%, both below the typical thresholds for healthcare facilities, which often aim for ROE above 10% and ROA above 5%. Operating income of EUR 1.37 million on revenue of EUR 48.76 million yields a 2.8% margin, which is weak compared to industry benchmarks. The company’s geographic exposure is concentrated in Germany, with three primary clinics in Bonn, Moenchengladbach, and Bad Wuennenberg. Revenue is not disclosed by segment, but the ownership structure suggests a focus on orthopedics, geriatrics, and cardiology. The company also holds a minority stake in a geriatric center, indicating diversification within the senior care segment. Growth appears limited, with the most recent actual revenue of EUR 36.91 million reported in the IR observations, compared to the latest financial snapshot of EUR 48.76 million. This suggests a recent increase, but the outlook for the next fiscal year is not explicitly provided. Free cash flow of EUR 651,000 and capital expenditures of EUR -871,000 indicate a net outflow, which may constrain reinvestment. Risk factors include medium liquidity risk due to a current ratio of 1.57 and a negative net cash position after debt. Dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted figures. The company’s capital structure is stable, but the low ROE and ROA suggest operational inefficiencies that could affect long-term value. Recent events include the rebranding from Eifelhoehen-Klinik AG to MedNation AG, reflecting a strategic shift toward a broader healthcare services identity. No recent filings or transcripts are provided, but the company’s ownership of multiple clinics and a minority stake in a geriatric center suggests a focus on expanding its footprint in Germany’s aging population.
Key takeaways
  • MedNation operates three German clinics focused on orthopedics, geriatrics, and cardiology, with a rebranding to reflect a broader healthcare services identity.
  • The company’s debt-to-equity ratio of 1.06 and negative net cash position after debt suggest moderate leverage and liquidity risk.
  • ROE of 0.9% and ROA of 0.29% are significantly below industry benchmarks, indicating weak profitability.
  • Free cash flow is limited at EUR 651,000, and capital expenditures are negative, suggesting reinvestment constraints.
  • Revenue is concentrated in Germany, with no disclosed segment breakdown, and growth appears modest based on recent actuals.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$48.8M
Gross profit$46.0M
Operating income$1.4M
Net income$104.7k
R&D
SG&A
D&A
SBC
Operating cash flow$2.3M
CapEx-$871.0k
Free cash flow$651.0k
Total assets$36.2M
Total liabilities$24.6M
Total equity$11.6M
Cash & equivalents$3.0M
Long-term debt$12.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$11.6M
Net cash-$9.4M
Current ratio1.6
Debt/Equity1.1
ROA0.3%
ROE0.9%
Cash conversion22.1%
CapEx/Revenue-1.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricEIFGActivity
Op margin2.8%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin0.2%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin94.3%19.7% medp25 19.7% · p75 39.8%top quartile
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-1.8%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity106.0%71.3% medp25 19.0% · p75 91.7%top quartile
Observations
IR observations
Last actual EPS0.28 EUR
Last actual revenue36,912,000 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 22:55 UTC#62615721
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 22:56 UTCJob: 5fd3933e